< Back to search
Filter
1

An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers

for
Lymphoma, Multiple Myeloma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18 - 70+

Code: NCT07226934

Recruiting

Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma

for
Relapse Multiple Myeloma, Refractory Multiple Myeloma
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT07093554

Phase1, Recruiting

Survivors Uniting for Remote Guided Exercise

for
Cancer,
Location: Fort Collins CO
Sponsor: Colorado State University

Sex: All

Age: 18+

Code: NCT07290309

Recruiting

Plan Development for Giving Teclistamab in the Outpatient Setting

for
Multiple Myeloma, Relapsed Cancer, Refractory Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06251076

Recruiting

Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager

for
Multiple Myeloma Refractory, Relapsed Multiple Myeloma
Location: Quebec, Levis
Sponsor: CHU de Quebec-Universite Laval

Sex: All

Age: 18+

Code: NCT07094048

Recruiting

Interested in new multiple myeloma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

for
Multiple Myeloma, Hodgkin Lymphoma, Non-hodgkin Lymphoma
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT07188090

Phase2, Recruiting

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

for
Multiple Myeloma
Location: Cleveland OH, San Francisco CA
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT07149857

Phase2, Recruiting

A Dietary Study for People With Multiple Myeloma

for
Multiple Myeloma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07226609

Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

for
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukaemia,
Location: Dallas TX, Salt Lake City UT
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 0+

Code: NCT06357754

Recruiting

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

for
Multiple Myeloma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT07101445

Recruiting

Two Step Haplo With Radiation Conditioning

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Philadephia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT05031897

Phase2, Recruiting

A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)

for
AML (Acute Myeloid Leukemia), Multiple Myeloma Refractory
Location: Camden NJ
Sponsor: Roger Strair

Sex: All

Age: 18+

Code: NCT07771803

Early_phase1, Recruiting

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

for
Multiple Myeloma, Triple Negative Breast Cancer,
Location: Boston MA
Sponsor: Andrew Hantel, MD

Sex: All

Age: 18+

Code: NCT07341867

Phase1, Recruiting

Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma

for
Multiple Myeloma, Plasma Cell Leukemia
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06517017

Phase2, Recruiting

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Philadelphia PA
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07463807

Phase1, Phase2, Recruiting

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, New York NY, Philadelphia PA, Charlotte NC,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18+

Code: NCT07116616

Phase1, Phase2, Recruiting

ERd Combination Treatment in Newly Diagnosed Multiple Myeloma (ADVANCE 2.0)

for
Multiple Myeloma
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06997081

Phase2, Recruiting

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Halifax, New Haven CT, Hackensack NJ, Toronto,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06988488

Phase1, Phase2, Recruiting

Selinexor and Backbone Treatments of Multiple Myeloma Patients

for
Multiple Myeloma
Location: Boston MA, Durham NC, Seattle WA
Sponsor: Karyopharm Therapeutics Inc

Sex: All

Age: 18+

Code: NCT02343042

Phase1, Phase2, Recruiting

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

for
Multiple Myeloma, Multiple Myeloma Progression,
Location: Charlotte NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 30+

Code: NCT06644625

Recruiting